Fundraising Fox

StemoniX

Eden Prairie, US · Founded 2014 · Minnesota corporation · 2 known investors

stemonix.com ↗
Biotech

Founders & leadership

StemoniX was founded in 2014 by Yung-Ping Yeh.

YY
Yung-Ping YehFounder
RG
Ryan GordonExecutive
MK
Murdoc KhaleghiExecutive
RP
Robert PetcavichNamed on SEC filing

Board

SS
Steven SnyderBoard director
PH
Paul HansenBoard director
KG
Kevin GundersonBoard director

Investors · 2

Brightstone Venture CapitalMinneapolis · $250K – $10M
Rockies Venture ClubDenver · $100K – $500K

Reported raises · per SEC filings

Form D private placements

$14.6M disclosed across 7 rounds · 2015–2020

▶$100KraisedMay 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sriram NadathurDirector
  • Patrick O'ShaughnessyDirector
  • Yung-Ping YehExecutive Officer, Director, Promoter
  • Paul HansenDirector
  • Kevin GundersonDirector
  • Andrew LaFrenceExecutive Officer, Promoter
  • Robert PetcavichExecutive Officer, Director, Promoter
Offering amount
$10.9M
Amount sold
$100K
Minimum investment
$25K
Placement agents
Boustead Securities, LLC, North Capital Private Securities Corporation
First sale
May 2020
Incorporated
Corporation, Minnesota
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedOct 2019 · 31 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Andrew LaFrenceExecutive Officer
  • Blake AnsonExecutive Officer
  • David BucheExecutive Officer
  • Ryan GordonExecutive Officer
  • Yung-Ping YehExecutive Officer, Director, Promoter
  • Steven SnyderDirector
  • Fabian ZanellaExecutive Officer
  • Paul HansenDirector
  • Patrick O'ShaughnessyDirector
  • Sriram NadathurDirector
  • Robert PetcavichExecutive Officer, Director, Promoter
  • Murdoc KhaleghiExecutive Officer
  • Kevin GundersonDirector
Offering amount
$6M
Amount sold
$2.1M
Minimum investment
$25K
Sales commissions
$32.3K
Placement agents
Boustead Securities, LLC
First sale
Sep 2019
Incorporated
Corporation, Minnesota
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$1.4MraisedAug 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew PerisExecutive Officer
  • Kevin GundersonDirector
  • Dimas JimenezExecutive Officer
  • Marcus BoehmDirector
  • Patrick O'ShaughnessyDirector
  • Steven SnyderDirector
  • Paul HansenDirector
  • David BucheExecutive Officer
  • Robert PetcavichExecutive Officer, Director, Promoter
  • Murdoc KhaleghiExecutive Officer
  • Yung-Ping YehExecutive Officer, Director, Promoter
  • Ryan GordonExecutive Officer
Offering amount
$12M
Amount sold
$1.4M
Minimum investment
$10K
First sale
Aug 2018
Incorporated
Corporation, Minnesota, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedJun 2018 · 64 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin GundersonDirector
  • Murdoc KhaleghiExecutive Officer
  • Steven SnyderDirector
  • Marcus BoehmDirector
  • Paul HansenDirector
  • Dimas JimenezExecutive Officer
  • Robert PetcavichExecutive Officer, Director, Promoter
  • Yung-Ping YehExecutive Officer, Director, Promoter
  • Patrick O'ShaughnessyDirector
  • David BucheExecutive Officer
  • Ryan GordonExecutive Officer
  • Matthew PerisExecutive Officer
Offering amount
$6M
Amount sold
$4.9M
Minimum investment
$10K
Sales commissions
$86.5K
Placement agents
Roth Capital Partners
First sale
Oct 2017
Incorporated
Corporation, Minnesota, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMar 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yung-Ping YehExecutive Officer, Director, Promoter
  • Robert PetcavichExecutive Officer, Director, Promoter
  • Kevin GundersonDirector
  • Paul HansenDirector
  • Ryan GordonExecutive Officer
  • Patrick O'ShaughnessyDirector
  • Steven SnyderDirector
  • Dimas JimenezExecutive Officer
  • Murdoc KhaleghiExecutive Officer
  • Matthew PerisExecutive Officer
  • Marcus BoehmDirector
  • Fabian ZanellaExecutive Officer
Offering amount
$6M
Amount sold
$2.4M
Minimum investment
$10K
Sales commissions
$295K
Placement agents
Cedar Point Capital, LLC
First sale
Feb 2017
Incorporated
Corporation, Minnesota, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedOct 2016 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marcus BoehmDirector
  • Murdoc KhaleghiExecutive Officer
  • Steven SnyderDirector
  • Paul HansenDirector
  • Ryan GordonExecutive Officer
  • Kevin GundersonDirector
  • Robert PetcavichExecutive Officer, Director, Promoter
  • Yung-Ping YehExecutive Officer, Director, Promoter
Offering amount
$2.5M
Amount sold
$2.5M
Minimum investment
$10K
First sale
Jul 2016
Incorporated
Corporation, Minnesota, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJan 2016 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan GordonExecutive Officer
  • Steven SnyderDirector
  • Robert PetcavichExecutive Officer, Director, Promoter
  • Yung-Ping YehExecutive Officer, Director, Promoter
  • Paul HansenDirector
  • Kevin GundersonDirector
  • Murdoc KhaleghiExecutive Officer
Offering amount
$2.3M
Amount sold
$1.1M
Minimum investment
$10K
First sale
Dec 2015
Incorporated
Corporation, Minnesota, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded StemoniX?
StemoniX was founded by Yung-Ping Yeh in 2014.
Who are StemoniX's investors?
StemoniX's investors include Brightstone Venture Capital, Rockies Venture Club.
How much funding has StemoniX raised?
StemoniX has disclosed $14.6M raised across 7 rounds.
Where is StemoniX headquartered?
StemoniX is headquartered in Eden Prairie, US.